The Neuron Clinic has expanded its neuroimaging capabilities through the purchase of two additional NeuroLF® systems, reinforcing the growing role of point-of-care brain PET imaging in routine neurological care.
The expansion follows the successful clinical adoption of the clinic’s first NeuroLF system in 2025, with the decision to scale occurring within months of initial deployment. This rapid uptake highlights the increasing demand for accessible, high-quality neuroimaging, particularly in the diagnosis and management of neurodegenerative diseases such as Alzheimer’s.
Developed by Positrigo, the NeuroLF system is a compact, dedicated brain positron emission tomography (PET) scanner designed to bring advanced molecular imaging directly into outpatient neurology clinics. By enabling on-site imaging, the platform reduces the need for referrals to large hospital-based imaging centres, streamlining workflows and improving patient access to diagnostic services.
The additional systems are scheduled for deployment across multiple clinic locations in Southern California, supporting the clinic’s strategy to scale decentralised imaging services. This model allows patients to undergo advanced brain imaging within community-based settings, reducing wait times and accelerating diagnostic pathways.
Point-of-care imaging is gaining traction as a key innovation in neurology, particularly as demand for early diagnosis continues to rise. In Alzheimer’s disease, timely detection is critical, especially with the emergence of disease-modifying therapies that require early intervention for optimal effectiveness.
The NeuroLF system’s compact design and integration into existing clinical workflows enable outpatient clinics to offer advanced imaging without the infrastructure requirements typically associated with full-body PET systems. This supports a shift toward more decentralised and patient-centric care models.
The expansion also reflects broader trends in medical imaging, where technologies are increasingly being developed to move diagnostics closer to the point of care. By combining accessibility with high-quality imaging, such systems aim to improve diagnostic confidence while reducing the burden on healthcare systems.
As neurological disorders continue to rise globally, innovations that enhance early detection and streamline care delivery are expected to play a critical role in improving patient outcomes. The Neuron Clinic’s investment in additional NeuroLF systems underscores the growing importance of scalable, accessible neurodiagnostic solutions in modern healthcare.
